Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $3.25 | Change: $-0.03 | %Change: -0.91%
Volume: 16,285 | Day High/Low: 3.25/3.24 | 52 Week High/Low: 5.73/1.42


View modes: 
5 stars

RE:RE:RE:RE:RE:RE:Q1 Results

There are the retail sales that MNK make and then there are the wholesale shipments that Nuvo makes which includes inventory. So while there were only a small number of scripts for Pennsaid 2% and...read more
5 stars

RE:RE:RE:RE:RE:Q1 Results

let me edit that last sentence: paddypower wrote: Did anyone note the sentence '' COGS increased due to  due to increased Pennsaid (P1) and Pennsaid 2% (P2) product sales.  '' How can that be...read more
3 stars

RE:RE:RE:RE:Q1 Results

Rocky Racoon: you do bring a bit of levity to the thread. So ta for that. Any chance you'll disclose your NRI holdings, not so much out of curiouslity, but just so we can judge what is '' small'' to...read more
5 stars

RE:RE:RE:RE:Q1 Results

Good question to ask, just how profitable is P2? I will continue to hold, as long as I can expect growth in all sources of revenue to occur, provided gross margins are maintanied. The NR for Q1...read more
5 stars

RE:RE:RE:Q1 Results

While the quarter reaks I can't say 6 weeks in  that P2 is a disappointment, lets give it at least two quarters to make that judgement. From what I gathered reading the CafeP website P2 is not covered...read more
2.5 stars

RE:RE:RE:Q1 Results

Little folk very angry that cash burn so low and cash build so robust. Expect them to dump more of their shares today. If they dump all (69 shares), it could be a rocky start. Lol  rate and reply
5 stars

RE:RE:Q1 Results

''Nice ramp up'' - yeah, nice ramp down, too.  It's nice to be nice, isnt it, Rocksinhead?....What reality do you subscribe to - Rocky 9 ? Q1 2013 43,000 P1 Pennsaid. 2014 24,000 P1 + 6,000 P2...read more
4.5 stars

RE:RE:Q1 Results

actually no news at all really, -sales income down -scripts down -P2% "launch" is a dud, like its predecessor launches everywhere -income from Zars purchase is missing in action -loans up -severe...read more
2 stars

RE:Q1 Results

Very solid quarter in transition to P2 sales ramp up.  Cash burn rate reduced to $900,000. NRI ended the quarter with a whopping $14.2 million in cash plus another $2 million very soon once forced...read more
4 stars

Q1 Results

Uninspiring! Thanks Dan and John for another losing quarter under your leadership. Nuvo Research loses $2.74-million in Q1 2014 Ticker Symbol: C:NRI Nuvo Research loses $2.74-million in Q1 2014 Nuvo...read more
4 stars

RE:Interesting battle

Sorry if you can't handle the truth, Rock. If you are going to post then try to make the effort to be accurate. Spin it all you want but don't bullsh*t people with half-truths or speculation based on...read more
1.5 stars

Interesting battle

Between the forced and the voluntary. C99 just dont waste our time with your transparent postings here. We are sick of the whinings of you Little Folk. Drop dead or better still, get a real life.  rate and reply
4 stars

RE:Cash position

The net change in cash and cash equivalents was reported to be $(2.025) Million in Q4. Nuvo received a one-time payment of $500 k in Q4 related to the Russian deal - otherwise the cash burn would be...read more
3 stars

Cash position

Cash and equivalents were $12.6 million at the end of Dec/13. The cash burn rate was $1.7 million in Q4. We shall soon receive the $2million US for Plialis plus another $5 million if forced...read more
3 stars

RE:RE:RE:RE:RE:Impressive afternoon of trading again

sorry, my appoligies as I screwed up with my math, lol.  A half warrant is attached to the purchase price with the placement, so it would be half as much. So there would be 695,000 full warrants...read more
3 stars

RE:RE:RE:RE:Impressive afternoon of trading again

Consultant: The private placement issued 1,390,000 shares at $2.25 per share. Raising $3,127,500 for the company. Attached to the placement purchase was a half warrant for every share purchased, each...read more
5 stars

RE:RE:RE:Impressive afternoon of trading again

Once again the question - why is someone willing to push the price up to force an early redemption of the warrants? There must be something relating to the value of owning more shares that is the...read more
5 stars

RE:RE:Impressive afternoon of trading again

If the price floats in the $3.30 to $3.70 range , with a consistant close above $3.50 over the next couple of weeks, then we will know that the purpose is just to likely get the warrants exercised. If...read more
3 stars

RE:Impressive afternoon of trading again

ronz wrote: Not bad.... another day of impressive afternoon momentum, with a close of $3.64/share. Obviously the forced warrent fix is in!  rate and reply
3 stars

Impressive afternoon of trading again

Not bad.... another day of impressive afternoon momentum, with a close of $3.64/share.  rate and reply